Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/19239
Title: PLX4032 and melanoma: resistance, expectations and uncertainty
Institution and School/Department of submitter: Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής
Keywords: Antineoplastic Agents/*therapeutic use,Drug Resistance, Neoplasm/*genetics,Humans,Indoles/*therapeutic use,Melanoma/*drug therapy/genetics,Mutation,Protein Kinase Inhibitors/*therapeutic use,Proto-Oncogene Proteins B-raf/genetics,Sulfonamides/*therapeutic use
URI: https://olympias.lib.uoi.gr/jspui/handle/123456789/19239
ISSN: 1744-8328
Link: http://www.ncbi.nlm.nih.gov/pubmed/21417847
http://www.expert-reviews.com/doi/pdfplus/10.1586/era.11.3
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
File Description SizeFormat 
Roukos-2011-PLX4032 and melanoma.pdf906.29 kBAdobe PDFView/Open    Request a copy


This item is licensed under a Creative Commons License Creative Commons